NIH-funded research R01 grant

Understanding unique proteins that help spirochetes move

Official title: Delineation of unique flagellar proteins in spirochetes

Funded at East Carolina University · NIH-11042857 · Data updated 2026-11-12

This study is looking at special proteins that help the Lyme disease bacteria move, with the goal of understanding how they work so we can find better ways to treat infections caused by these germs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Carolina University
NIH-funded
Lab location1 site (Greenville, United States)
Project startFebruary 23, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$519,498
NIH project number5R01AI132818-06
Project IDNIH-11042857 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lyme disease or other conditions caused by spirochetal bacteria.

Less likely to help

Patients with non-spirochetal infections or those not affected by Lyme disease may not benefit from this research.

What this research studies

This research investigates the unique flagellar proteins in spirochetes, particularly focusing on the Lyme disease-causing bacterium Borrelia burgdorferi. By examining the molecular mechanisms that allow these bacteria to move, the research aims to uncover how specific proteins contribute to their motility and pathogenicity. The study employs advanced biochemical and bioinformatics techniques to characterize these proteins and their roles in the assembly of flagella, which are crucial for the bacteria's ability to infect hosts. This work is essential for developing new treatment strategies against diseases caused by spirochetes.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients suffering from Lyme disease and other spirochetal infections.

How similar studies have gone: While spirochetes have been studied, this specific focus on their unique flagellar proteins represents a novel approach that has not been extensively explored.

Where this research is happening

  • East Carolina University
    Greenville, United States
    Active

Researchers

  • Principal investigator: Motaleb, Md a — East Carolina University
  • Study coordinator: Motaleb, Md a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.